Legal Representation
Attorney
John Alumit
USPTO Deadlines
Next Deadline
421 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210216)
Due Date
February 16, 2027
Grace Period Ends
August 16, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
31 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 16, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 13, 2021 | DP1B | I | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | Loading... |
| Dec 22, 2020 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
| Dec 22, 2020 | D1BR | I | TEAS DELETE 1(B) BASIS RECEIVED | Loading... |
| Dec 22, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 27, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 27, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 7, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 22, 2020 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE | Loading... |
| Sep 18, 2020 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
| Sep 11, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 18, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 18, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 16, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 29, 2020 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Mar 11, 2020 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Mar 11, 2020 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Mar 11, 2020 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Mar 10, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 9, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 9, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 30, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 30, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 30, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 23, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 3, 2019 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Jul 11, 2019 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Aug 27, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 13, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 11, 2019 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Jul 8, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medical diagnostic test strips for diabetics; Medical diagnostic test reagents for diabetics; medical diagnostic test kit comprised of medical diagnostic reagents and assays for testing viral infections; Diagnostic test reagents for veterinary purposes; Medical diagnostic reagents for use in genetic diseases testing; Medical diagnostic test reagents for use in genetic diseases testing; Medical diagnostic strips for glycated hemoglobin; Medical diagnostic test reagents for blood glucose; Medical diagnostic strips for liver disease; Medical diagnostic test reagents for liver disease; Medical diagnostic test reagents for glycated hemoglobin; Reagent paper for medical purposes; Medical diagnostic strips for cardiac disease; Medical diagnostic test reagents for cardiac disease; Medical diagnostic test reagents for cancerous diseases; Medical diagnostic strips for cancerous diseases; Medical diagnostic strips; Diagnostic test reagents for medical purposes; Diagnostic agents for medical use; Medical diagnostic test reagents for cholesterol; Medical diagnostic strips for cholesterol; Medical diagnostic strips for blood glucose; Reagents for clinical medical tests; Diagnostic kit comprised of medical diagnostic reagents and assays for testing contagious infection symptoms
Additional Information
Design Mark
The mark consists of the stylized letters "OHC" and below the wording "OSANG HEALTHCARE".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"HEALTHCARE"